PedAM
Pediatric Disease Annotations & Medicines
| Disease | multiple sclerosis |
| Symptom | C0002766|analgesia |
| Sentences | 1 |
| PubMedID- 22629287 | One study with 12-month follow-up concluded there may be sustained analgesia for pain associated with multiple sclerosis, where about 30% of cannabinoid-treated participants report continued “improvement” at 12 months compared to about 15% on placebo on doses conservatively limited to a maximum of 25mg thc daily. |
Page: 1